Callie Hart
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,515 | 260 | 99.3% |
| Education | $32.64 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,035 | 78 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $593.85 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $508.28 | 30 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $258.76 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $247.34 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $229.21 | 11 | $0 (2024) |
| QOL Medical, LLC | $220.81 | 12 | $0 (2024) |
| GENZYME CORPORATION | $206.64 | 11 | $0 (2024) |
| Lilly USA, LLC | $206.31 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $187.19 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,786 | 144 | ABBVIE INC. ($647.23) |
| 2023 | $1,272 | 91 | ABBVIE INC. ($350.23) |
| 2022 | $464.62 | 25 | Regeneron Healthcare Solutions, Inc. ($90.97) |
| 2021 | $24.44 | 2 | QOL Medical, LLC ($12.48) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.91 | General |
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/27/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.78 | General |
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.09 | General |
| Category: GI | ||||||
| 11/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: LIVER DISEASE | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 230 | 297 | $54,014 | $19,287 |
| 2022 | 5 | 226 | 311 | $54,016 | $20,516 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 151 | $30,351 | $10,921 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 94 | $13,348 | $4,727 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,550 | $2,262 | 34.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 15 | $1,665 | $724.92 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,100 | $651.15 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 147 | $29,547 | $10,907 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 84 | $11,928 | $4,539 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 49 | $5,439 | $2,286 | 42.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $4,220 | $1,775 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,882 | $1,009 | 35.0% |
About Callie Hart
Callie Hart is a Student in an Organized Health Care Education/Training Program healthcare provider based in Mt Pleasant, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2020. The National Provider Identifier (NPI) number assigned to this provider is 1104458942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Callie Hart has received a total of $4,547 in payments from pharmaceutical and medical device companies, with $2,786 received in 2024. These payments were reported across 262 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,515).
As a Medicare-enrolled provider, Hart has provided services to 456 Medicare beneficiaries, totaling 608 services with total Medicare billing of $39,803. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Physician Assistant
- Location Mt Pleasant, MI
- Active Since 02/10/2020
- Last Updated 01/10/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104458942
Products in Payments
- XIFAXAN (Drug) $553.75
- STELARA (Biological) $439.60
- DUPIXENT (Biological) $393.83
- ZENPEP (Drug) $293.27
- LINZESS (Drug) $281.58
- RINVOQ (Biological) $220.85
- CREON (Drug) $207.28
- OMVOH (Drug) $206.31
- SUCRAID (Drug) $160.38
- TREMFYA (Drug) $156.96
- VIBERZI (Drug) $126.73
- ENTYVIO (Biological) $114.30
- SKYRIZI (Biological) $103.69
- MAVYRET (Drug) $94.45
- XELJANZ (Drug) $83.51
- SUFLAVE (Drug) $80.87
- EOHILIA (Drug) $78.63
- IBSRELA (Drug) $69.39
- DIFICID (Drug) $61.71
- Linzess (Drug) $60.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Mt Pleasant
Dr. Nicolas Mazal, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,668
Lee Yarbrough, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $11,252
Benfauzi El-Attrache
Student in an Organized Health Care Education/Training Program — Payments: $5,112
Matthew Jaenicke, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,249
Alban Tomaj
Student in an Organized Health Care Education/Training Program — Payments: $757.33
Omar Zuhdi
Student in an Organized Health Care Education/Training Program — Payments: $124.74